z-logo
open-access-imgOpen Access
Deletion ofIKZF1and Prognosis in Acute Lymphoblastic Leukemia
Author(s) -
Charles G. Mullighan,
Xiaoping Su,
Jinghui Zhang,
Ina Radtke,
Letha A. Phillips,
Christopher B. Miller,
Jing Ma,
Wei Liu,
Cheng Cheng,
Brenda A. Schulman,
Richard C. Harvey,
IMing Chen,
Robert Clifford,
William L. Carroll,
Gregory H. Reaman,
W. Paul Bowman,
Meenakshi Devidas,
Daniela S. Gerhard,
Wenjian Yang,
Mary V. Relling,
Sheila Shurtleff,
Dario Campana,
Michael J. Borowitz,
ChingHon Pui,
Malcolm A. Smith,
Stephen P. Hunger,
Cheryl L. Willman,
James R. Downing
Publication year - 2009
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0808253
Subject(s) - medicine , oncology , cohort , gene expression profiling , acute lymphocytic leukemia , gene signature , leukemia , gene , immunology , bioinformatics , genetics , gene expression , biology , lymphoblastic leukemia
Despite best current therapy, up to 20% of pediatric patients with acute lymphoblastic leukemia (ALL) have a relapse. Recent genomewide analyses have identified a high frequency of DNA copy-number abnormalities in ALL, but the prognostic implications of these abnormalities have not been defined.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom